Adult human epidermal melanocytes for neurodegeneration research

NeuroReport

Volumn 19, Issue 18, 2008, Pages 1787-1791

  Papageorgiou, Nikolaos ^a,b   Carpenter, Elisabeth ^a   Scally, Andrew J ^a   Tobin, Desmond J ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

amyloid (1 40); Alzheimer's disease; Amyloid protein precursor; Fibroblasts; Melanocytes

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN; ISOPROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL MODEL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTE; NERVE DEGENERATION; PRIORITY JOURNAL;

AGE FACTORS; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMIS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOCYTES; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PEPTIDE FRAGMENTS;

EID: 57149134522     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283193e82     Document Type: Article

References (23)

1. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81:741-766.
2. Knapp M, Prince M, Albanese E, Banerjee S, Dhanasiri S, Fernandez J-L et al. Dementia UK (A report to the Alzheimer's society on the prevalence and economic cost of dementia in the UK produced by King's College London and London School of Economics). London: Alzheimer's Society; 2007.
3. Selkoe DJ. Developing preventive therapies for chronic diseases: lessons learned from Alzheimer's disease. Nutr Rev 2007; 65:5239-5243.
4. Passer B, Pellegrini L, Russo C, Siegel RM, Lenardo MJ, Schettini G et al. Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J Alzheimers Dis 2000; 2:289-301.
5. Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 2001; 7:548-554.
6. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003; 43:545-584.
7. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989; 245:417-420.
8. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ et al. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem 1999; 274:18851-18856.
9. Karten B, Hayashi H, Campenot RB, Vance DE, Vance JE. Neuronal models for studying lipid metabolism and transport. Methods 2005; 36:117-128.
10. Luo BY, Xu ZB, Chen Z, Chen F, Tang M. Investigation on apoptosis of neuronal cells induced by amyloid beta-protein. J Zhejiang Univ Sci 2004; 5:989-994.
11. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004; 84:1155-1228.
12. Yaar M, Gilchrest BA. Human melanocytes as a model system for studies of Alzheimer disease. Arch Dermatol 1997; 133:1287-1291.
13. Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest 1997; 100:2333-2340.
14. Kauser S, Schallreuter KU, Thody AJ, Gummer C, Tobin DJ. Regulation of human epidermal melanocyte biology by beta-endorphin. J Invest Dermatol 2003; 120:1073-1080.
15. Kauser S, Slominski A, Wei ET, Tobin DJ. Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J 2006; 20:882-895.
16. Fiore F, Zambrano N, Minopoli G, Donini V, Duilio A, Russo T. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/ phosphotyrosine binding domain of She bind the intracellular domain of the Alzheimer's amyloid precursor protein. J Biol Chem 1995; 270:30853-30856.
17. Cao X, Sudhof TC. Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem 2004; 279: 24601-24611.
18. McLoughlin DM, Miller CC. The FE65 proteins and Alzheimer's disease. J Neurosci Res 2008; 86:744-754.
19. Tan J, Town T, Placzek A, Kundtz A, Yu H, Mullan M. Bcl-X(L) inhibits apoptosis and necrosis produced by Alzheimer's beta-amyloid 1-40 peptide in PC12 cells. Neurosci Lett 1999; 272:5-8.
20. Yaar M, Zhai S, Fine RE, Eisenhauer PB, Arble BL, Stewart KB et al. Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem 2002; 277:7720-7725.
21. Golabek AA, Kida E, Walus M, Perez C, Wisniewski T, Soto C. Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E. Biophys J 2000; 79:1008-1015.
22. Cedazo-Minguez A, Wiehager B, Winblad B, Huttinger M, Cowburn RF. Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts. Neurochem Int 2001; 38:615-625.
23. Zhang Y, Hong Y, Bounhar Y, Blacker M, Roucou X, Tounekti O et al. p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity. J Neurosci 2003; 23:7385-7394.